论文部分内容阅读
目的:分析布地奈德雾化吸入与硫酸镁联用对急性支气管哮喘患者的疗效及护理对策。方法:选取2012年10月—2014年10月间收治的急性支气管哮喘患者80例,将其分为对照组和观察组,每组40例;两组患者均予布地奈德雾化吸入与硫酸镁联用治疗,对照组患者在此基础上给予常规护理治疗,观察组患者在对照组治疗基础上给予护理干预治疗,比较两组患者治疗后的疗效经简化舒适状况量表(general comfort questionnaire,简称GCQ)的评分值与肺功能指标。结果:经治疗、护理后,观察组患者的生理因素、社会文化因素、心理因素等评分值均高于对照组(P<0.05);观察组患者的FEV_1(1 s用力呼吸容积)、FVC(用力肺活量)、FEV_1%值均显著高于对照组(P<0.05)。结论:布地奈德雾化吸入与硫酸镁联用治疗急性支气管哮喘患者护理干预治疗后的疗效优于常规护理治疗,促进了患者肺功能的改善,提高了其治疗舒适度。
Objective: To analyze the curative effect and nursing countermeasure of budesonide inhalation combined with magnesium sulfate in patients with acute bronchial asthma. Methods: Eighty patients with acute bronchial asthma who were admitted from October 2012 to October 2014 were selected and divided into control group and observation group, 40 cases in each group. Both groups were given budesonide inhalation with sulfuric acid Magnesium combined with treatment, the control group of patients on the basis of this routine nursing treatment, the observation group patients in the control group based on the nursing interventions, the efficacy of the two groups were compared after treatment by the simplified comfort status scale (general comfort questionnaire, Referred to as GCQ) score and lung function index. Results: After treatment and nursing, the scores of physiological, socio-cultural and psychological factors in the observation group were higher than those in the control group (P <0.05). The FEV 1 (forced respiration volume of 1 s), FVC Forced vital capacity), FEV_1% values were significantly higher than the control group (P <0.05). Conclusion: The efficacy of budesonide inhalation combined with magnesium sulfate in the treatment of patients with acute bronchial asthma is better than that of routine nursing care, which improves the pulmonary function and improves the treatment comfort.